Literature DB >> 2822219

Immunohistochemical determination of immunosuppressive acidic protein in reactive and neoplastic diseases of macrophage.

K Aozasa1, T Ueda, M Ayata, M Tsujimoto, M Q Fujita, T Yamamura, T Tsujimura.   

Abstract

Immunosuppressive acidic protein (IAP), a substance purified from cancer ascitic fluid, is released into the culture medium of macrophages and neutrophils, and is supposed to suppress an immune function of the host. Elevation of serum IAP in cancer patients has been reported. In the current study, presence of IAP in proliferating diseases of macrophage was examined. Macrophages in reactive proliferation, histiocytosis X, and neoplastic proliferation gave positive reaction for IAP. Diffuse cytoplasmic staining was usual, but dot-like or globular and surface staining also were observed. Proliferating cells in malignant fibrous histiocytoma were more sensitively stained by IAP than by other ordinary used markers for macrophage. These findings provide useful information to understand the mechanism of elevation of serum IAP in cancer patients.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2822219     DOI: 10.1002/1097-0142(19871115)60:10<2424::aid-cncr2820601012>3.0.co;2-2

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  4 in total

1.  Perioperative allogenic blood transfusion and serum levels of immunosuppressive acidic protein in patients undergoing resection of colorectal carcinoma.

Authors:  T Iwanaga; H Suzuki
Journal:  Dig Dis Sci       Date:  1999-08       Impact factor: 3.199

2.  Preoperative serum immunosuppressive acidic protein (IAP) test for the prognosis of gastric cancer: a statistical study of the threshold level and evaluation of the effect of the biological response modifier PSK.

Authors:  J Sakamoto; A Koike; S Saji; S Teramukai; Y Ohashi; H Nakazato
Journal:  Surg Today       Date:  1992       Impact factor: 2.549

3.  Alpha 1-acid glycoprotein expression in human leukocytes: possible correlation between alpha 1-acid glycoprotein and inflammatory cytokines in rheumatoid arthritis.

Authors:  T Nakamura; P G Board; K Matsushita; H Tanaka; T Matsuyama; T Matsuda
Journal:  Inflammation       Date:  1993-02       Impact factor: 4.092

4.  Immunosuppressive acidic protein serum levels in breast cancer patients in a reference to CA 15-3 levels.

Authors:  A D Cohen; Y Shoenfeld; J Gopas; Y Cohen
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.